Hong Xue

Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Laiyang Jiangbo Pharmaceuticals Co. Ltd. engages in the research, development, production, marketing, and sale of chemical drugs and traditional Chinese medicines in the People's Republic of China. Its products include itopride hydrochloride granules, and clarithromycin sustained-release, ciprofloxacin hydrochloride, baobaole chewable tablets & paracetamol tablets. The company offers products in the form of tablets, capsules, and granules for Western and Chinese herbal-based medical drugs. It sells its products through distribution sales network. The company was founded in 2003 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.

Jiangbo Pharmaceuticals, Inc. operates as a holding company. It operates, controls and owns the pharmaceutical business of Laiyang Jiangbo, which researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in China. The company was founded on August 15, 2001 and is headquartered in Yantai, China.